The invention relates to methods for treating pruritus with an NK-1 receptor antagonist. The invention further relates to pharmaceutical compositions comprising NK-1 receptor antagonist.
-
Page/Page column 7
(2014/12/12)
POLYMORPHS OF A HYDROISOINDOLINE TACHYKININ RECEPTOR ANTAGONIST
This application is directed to a novel polymorph of a hydroisoindoline tachykinin receptor antagonist having the following structural formula A.
-
Page/Page column 18-19
(2008/12/05)
Process for making hydroisoindoline tachykinin receptor antagonists
The present invention is directed to a process for preparing certain hydroisoindoline compounds which are useful as neurokinin-1 (NK-1) receptor antagonists, and inhibitors of tachykinin and in particular substance P. The compounds are useful in the treatment of certain disorders, including emesis, urinary incontinence, depression, and anxiety.
-
Page/Page column 10; 11
(2008/06/13)
More Articles about upstream products of 920025-40-7
Get Best Price for920025-40-74-Cyclohexene-1,2-dicarboxylic acid,
3-(4-fluorophenyl)-4-[(triethylsilyl)oxy]-,
1,2-bis[(1R,2S,5R)-5-methyl-2-(1-methylethyl)cyclohexyl] ester,
(1S,2S)-